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Tuberous sclerosis complex (TSC) is a genetically inherited condition 
that manifests with benign non-invasive hamartomas in multiple 
organ systems and is associated with varied clinical presentations.[1,2] 
The prevalence of TSC worldwide is reported as 1 in 6 000 newborns.[1-4] 
Equivalent data from Africa are lacking. In Africa, the burden of disease is 
dominated by infectious aetiologies. People with non-communicable 
disorders, especially of genetic origin, have access to scarce resources 
and are managed as low-priority cases. This results in disparate out-
comes, e.g. in well-resourced settings awareness of TSC is more likely 
to lead to early diagnosis, whereas in Africa management is reactive, 
and limited resources and poor awareness lead to delayed diagnosis 
and intervention.
Red Cross War Memorial Children’s Hospital (RCWMCH), Cape 
Town, South Africa (SA) is unique in that it provides a dedicated 
TSC service in the paediatric neurology department. The service 
was established >15 years ago and has, during this period, managed 
45 affected children. Based on international prevalence figures, this 
number is less than expected for the region and raises concerns that 
only a proportion of affected children access the service. The referral 
pattern and disease demographics of the service were examined to 
identify remedial factors to improve diagnosis and service delivery.
Objective
The objective of this study was to document the phenotype of SA 
children with TSC, identifying clinical features at presentation, which 
could lead to improvements in diagnosis in our setting. 
Methods 
RCWMCH is a university teaching hospital located in the Western 
Cape, SA. For children with TSC a dedicated multidisciplinary ser-
vice operates in the paediatric neurology department, in line with 
international management guidelines. Patients are referred to our 
hospital by local health practitioners, based on concerns that arise 
from the complications of TSC. As such, the understanding of referral 
patterns was considered important to develop interventions to pro-
mote earlier identification of affected children, which would facilitate 
preventive rather than reactive interventions. 
All children attending the service between October 2013 and 
August 2016 were prospectively recruited.
Patient demographics were recorded and compared with inter-
national data (Table 1).[5-7] Age at presentation, referral sources and 
reason for referral were also documented. 
Ethical clearance to conduct the study was granted by the Faculty of 
Health Sciences Research Ethics Committee, University of Cape Town 
(ref. no. 020/2013). Written consent was obtained from caregivers. 
Results
Over the 33-month period, consent was obtained for 39 children 
(23 males, 16 females; median 10 (range 1 - 26) years), who fulfilled 
the international diagnostic criteria for TSC, to be part of the study. 
From the original cohort attending the service (n=45), 5 children 
had been referred to adult services, and 1 child died because of 
complications unrelated to his TSC diagnosis.
Sixteen children were of indigenous black African ancestry, 9 were 
white, 13 of mixed ancestry and 1 was Arabic. Median age at diagnosis 
was 16 (0 - 153) months (Table 1).
Twenty-one (54%) children were referred to the general neuro-
logy service owing to focal seizures, where TSC was diagnosed. 
Diagnosis was delayed in four children. Two were mislabelled on 
neuroimaging, specifically with neurocysticercosis in one child and 
congenital cytomegalovirus in another. TSC was diagnosed fol-
lowing identification of hypopigmented skin lesions in the former 
child and after persistent hypertension and identification of renal 
angiomyolipomas in the latter. A third child suffered recurrent 
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pancreatitis, and her skin lesions were initially thought to be due to 
a fungal infection. She eventually underwent a brain magnetic reso-
nance imaging (MRI) scan and the skin lesions were re-examined. 
A fourth child was resident in a rural part of the country. His learn-
ing and behavioural problems were well known to his caregivers, but 
he attended the health service only when he was 12 years and 9 months 
of age, with poorly controlled seizures. 
Seven (18%) children had epileptic spasms, 4 at presentation, and 
3 with focal seizures later developed spasms. The median lag time 
from onset of epileptic spasms to diagnosis and intervention was 3 (2 
- 8) months. Skin manifestations led to referral in 13 (33%) children, 
who were already being managed for seizures. Neuroimaging as part 
of routine screening for seizures resulted in confirmation of TSC in a 
further 22 (56%) children. Three children with cardiac rhabdomyo-
mas were identified antenatally, and 1 child with a positive family his-
tory was also diagnosed antenatally. 
Most children were referred to the general neurology service as emer-
gency cases with prolonged convulsive seizures, and a smaller proportion 
were referred from the medical outpatient service with brief seizures. The 
hospital location of the child at the time of diagnosis was distributed as 
follows: medical outpatients (n=9), paediatrics (n=9), neurology (n=15), 
antenatal obstetric service (n=3), and 1 each for genetics, gastroenterol-
ogy and dermatology services. The key marker that led to the diagnosis 
of TSC was predominantly based on neuroimaging findings after routine 
investigation for seizures in children managed in the medical outpatient 
service, and after the identification of skin lesions for children man-
aged in the neurology service. Comparison between these diagnostic 
markers for medical outpatients compared with neurology outpatients 
demonstrated a trend, but it was not statistically significant on Fisher’s 
exact test (p=0.058).
Prior to 2007, the median value for the number of new children 
with TSC who were referred to the service was 1 per year; from 2007, 
this number increased to a median value of 3 per year. 
Discussion
This study illustrated that awareness of TSC in SA health services 
is poor. TSC was suspected in only a few children, based on the 
presence of skin lesions; their referral to the neurology service 
was typically because of recurrent seizures. Most of the remaining 
children presented after acute presentations with seizures, and the 
diagnosis of TSC was made following admission for emergency 
management. Children in our cohort presented later than those 
reported in international studies (Table 1). As found in our study 
and in large international studies, the presenting features of TSC 
can be diverse – prior to their diagnosis a proportion of our children 
were under direct management in the genetics, gastroenterology and 
dermatology services.[4] The skin manifestations of 2 of the patients were 
detected, but incorrectly interpreted. In settings where conditions 
such as neurocysticercosis are prevalent, erroneous assumptive diag-
noses based on neuroimaging findings may also occur, as illustrated 
in this study. 
Hypomelanocytic macules may be present at birth, and other skin 
manifestations such as facial angiofibroma and shagreen patches 
appear later during the first decade of life.[2] In this study, even though 
hypomelanocytic macules were found in 69% of patients, the diag-
nosis of TSC was suspected at referral in only 33% of cases (Table 1). 
The 2012 international guidelines on the diagnosis and manage-
ment of TSC emphasise the importance of early diagnosis to improve 
the outcome of affected children.[1] Epileptic spasms are common 
during the first year of life in children with TSC. These children may 
also have focal seizures, which may occur either before or after onset 
of epileptic spasms. Corticosteroids are the recommended treatment 
for infants with epileptic spasms who do not have TSC, while vigaba-
trin is the most effective intervention in infants with TSC.[8] Delayed 
recognition of TSC can lead to suboptimal intervention for epileptic 
encephalopathy. The guidelines recommend presymptomatic electro-
encephalography (EEG) in the age group at risk of epileptic spasms.[2,5] 
Table 1. Demographics of children attending the TSC service from October 2013 to August 2016 compared with those of other 
similar paediatric cohort studies[5-7]
Variable Current study, N=39 Yates et al.,[5] N=114
Datta et al.[6]
(infants only), N=41         Erol et al.,[7] N=20
Male:female 23:16 62:63 24:17 10:10
Age at presentation (months), median 16 7 1.5 11 
Subependymal giant cell astrocytomas,* n (%) 10 (26) 5 (4) 4 (10) 1 (5)
Epilepsy, n (%) 34 (87) - - 17 (85)
Focal epilepsy, n (%) 21 (54) - - 7 (35)
Epileptic spasms (3 focal epilepsy and 
epileptic spasms), n (%) 
7 (18) - - 7 (35)
Cortical tubers,* n (%) 31 (79) 93 (89) 35 (85) 16 (80)
Subependymal nodules,* n (%) 36 (92) 76 (73) 37 (90) 16 (80)
Intellectual disability, n (%) 23 (59) 75 (85) - 5/8 (63)
Angiomyolipoma,* n (%) 17 (44) 13 (12) 6 (15) 1 (5)
Cardiac rhabdomyoma,* n (%) 8 (20) 51 (58) 35 (85) -
Facial angiofibroma,* n (%) 19 (49) 24 (29) 24 (29) 8 (40)
>3 hypomelanotic macules,* n (%) 27 (69) 80 (65) 21 (51) 17 (85)
Shagreen patch,* n (%) 10 (28) 30 (24) 30 (73) 2 (10)
Ungual and periungual fibroma,* n (%) 1 (0.02) 3 (2) - -
*International diagnostic criteria.[2]
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While this is a viable intervention at our centre, patients in this study 
typically had already evolved seizures as a presenting complaint. 
Furthermore, EEG is a scarce resource in low- and low-middle- 
income countries in Africa and many centres struggle to access such 
testing. Epileptic spasms were identified in 18% of the children in our 
study, which is similar to the percentage in other studies.[9]
The guidelines have similar recommendations for renal monitoring 
to screen for angiomyolipomas. Even though this is also a rational 
recommendation, it is unlikely to be fullfilled in many parts of sub-
Saharan Africa.[1,2,10] In our group, 3 patients presented with cardiac 
rhabdomyomas, and 5 had lesions identified after TSC was diagnosed. 
It is possible that these additional cases reflected limited antenatal 
assessment, and further highlights the difficulties of early detection 
in our setting.[11] The challenges illustrated here highlight the need 
for these children to be managed in a tertiary setting, where adequate 
multidisciplinary care can be provided, and the drain on already 
stretched secondary and primary healthcare services can be avoided. 
The study by Yates et al.[5] reported similar presentation triggers 
and phenotypic features as in our cohort, but in a population in the 
UK. One hundred and fourteen children in this study met the criteria 
for TSC and 17% were diagnosed in the antenatal period, compared 
with 8% of our patients.[5] Thirty children (24%) in the UK study 
presented before the onset of seizures, which affected 77 (62%) of the 
group.[5] In our population, the diagnosis of TSC before neuro imaging 
for new onset of seizures occurred less often than in the Yates et al.[5] 
study, but the proportion of children presenting with seizures was 
comparable (62% in the UK study v. 56% in the current study). The 
UK study also found an increasing number of children presenting 
prenatally or in early infancy, which reflected both the increased 
awareness of TSC and appropriate resources available to identify 
affected patients.[5]
The international TSC guidelines also recommend early neuro-
developmental screening to optimise performance outcomes. This 
would permit appropriate school placement and learning support 
to be initiated. There are challenges to such implementation in our 
setting, especially where there are additional compounding factors 
of poor socioeconomic structure, and layering effects from other 
comorbidities, such as HIV and tuberculosis. In most parts of Africa, 
there is limited access to developmental intervention, with few skilled 
health practitioners and long waiting lists.
Subependymal giant cell astrocytomas (SEGAs) are some of the 
more serious complications of TSC. International guidelines recom-
mend regular monitoring and awareness of early symptoms and signs 
to facilitate early intervention.[1] The current study found a higher 
proportion of children with SEGAs compared with the UK, USA and 
Turkey.[5-7] This may reflect disease behaviour, whereby only the most 
symptomatic patients access healthcare services in our setting. In SA, 
there is no effective structure for routine screening of asymptomatic 
children for TSC. 
Genetic testing is useful to confirm the diagnosis of TSC and 
for family counselling.[5] Currently, genetic testing is not routinely 
available in SA and fulfilment of clinical criteria is used to confirm 
a diagnosis of TSC. However, the service does have access to genetic 
counsellors, who provide families with support. A previous study[12] 
showed that caregivers, who despite regular attendance at the clinic, 
often failed to understand the condition and benefited when pro-
vided with written information, preferably in their home language 
or language of choice. This study highlights that there is a great need 
to raise awareness of TSC in our setting. Based on service referral 
patterns, opportunities to achieve this could be by promoting TSC 
teaching in undergraduate curricula, in community projects, and by 
raising awareness in primary healthcare clinics. Informative posters 
could be placed in strategic settings, such as primary healthcare clin-
ics and community centres. In SA, a national TSC non-governmental 
organization is yet to be established, but there are other routes of 
support, such as Rare Diseases SA (http://rarediseases.co.za/) and 
Epilepsy SA (http://epilepsy.org.za). 
Many of the patients were incidentally diagnosed by neuroimaging 
performed as part of evaluation of their seizure disorder. In our set-
ting, neuroimaging is not usually performed unless there is concern 
of focal pathology. Further, in our experience seizures are often 
erroneously assumed to be generalised, also reducing the likelihood 
of performing neuroimaging. This highlights the need for extracting 
a good clinical seizure semiology and performing a careful clinical 
examination, as the majority of affected children have skin manifesta-
tions. Since 2007, the RCWMCH TSC service has actively promoted 
awareness of common clinical markers for TSC within the hospital 
structure – a tertiary care facility. The median annual referral rate has 
tripled. While this is a positive trend, heightened awareness needs 
to be facilitated at primary and secondary facilities as the next stage. 
Based on the apparent scarcity of recognition and limited awareness 
of TSC in SA, which, compared with other parts of Africa, has greater 
access to resources, it is likely that the challenges of diagnosing TSC are 
even more pronounced in the rest of the continent. The late diagnosis 
of TSC in adulthood is associated with greater complications.[13]
Conclusion
In this study, most children with TSC presented as emergency 
cases with seizures. Awareness of the common clinical markers at 
presentation is lacking. We aimed to gain insight into the referral 
patterns of children with TSC to a specialised service to identify 
ways to improve early identification of and intervention with regard 
to the condition. The next stage will be an intervention study to 
observe if the recruitment can be improved by raising awareness in 
the key locations where these children present, inclusive of primary 
healthcare clinics, community bases, and school healthcare clinics.
TSC prevalence is estimated internationally at 1 in 6 000 newborns, 
and based on our population of 2.14 million children <19 years of age 
in the Western Cape, some 357 children in this region may have TSC.[14] 
The majority of affected children in our area and potentially sub-Saharan 
Africa are probably not diagnosed. This highlights the need to raise 
awareness of such common clinical markers to promote early referral to 
specialist centres to reduce complications. 
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